Age related macular degeneration
|
0.410 |
GeneticVariation
|
disease |
GWASDB |
Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis.
|
23326517 |
2013 |
Age related macular degeneration
|
0.410 |
Biomarker
|
disease |
BEFREE |
Haplotype analysis supported our findings of single SNP association, demonstrating that the most significant haplotype, GATAGTTCTC, spanning CFH, CFHR4, and CFHR2 was associated with the greatest risk of developing neovascular AMD (P < 10-6).
|
18541031 |
2008 |
Age related macular degeneration
|
0.410 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
C3 glomerulopathy
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN.
|
27458560 |
2016 |
C3 glomerulopathy
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Complement factor H-related hybrid protein deregulates complement in dense deposit disease.
|
24334459 |
2014 |
Complement deficiency disease
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
von Willebrand's factor (lab test)
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Ischemic stroke is associated with the ABO locus: the EuroCLOT study.
|
23381943 |
2013 |
Diabetes Mellitus, Insulin-Dependent
|
0.010 |
Biomarker
|
disease |
BEFREE |
Youth with T1DM had significantly increased amounts of complement factor H related protein 2 (FHR2; adjusted P < 0.05), compared to HC.
|
30922315 |
2019 |
Drusen
|
0.010 |
Biomarker
|
disease |
BEFREE |
Among the identified proteins, eight proteins, including APOA1, CFHR2, and CLUS, were previously considered major components or regulators of drusen.
|
30404605 |
2018 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.010 |
Biomarker
|
disease |
BEFREE |
To assess the ability of plasma apolipoprotein (apo) A-IV (apoA4), apo C-III, CD5 antigen-like (CD5L), complement C1q subcomponent subunit B (C1QB), complement factor H-related protein 2, and insulin-like growth factor binding protein 3 (IBP3) to predict rapid decline in estimated glomerular filtration rate (eGFR) in type 2 diabetes.
|
28851702 |
2017 |
Ankylosing spondylitis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The stratified analyses for AAU patients with ankylosing spondylitis (AS) revealed a reduced frequency of the A allele in CFHR2-rs2986127 compared to controls (p = 0.033, odds ratio = 0.563, 95% confidence interval = 330-0.960).
|
27306586 |
2016 |
Acute anterior uveitis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The present study reveals an association between CFHR2-rs2986127 and AAU diagnosis, especially with respect to gender, AS status and other clinical signs, such as posterior segment involvement.
|
27306586 |
2016 |
Glycogen storage disease type II
|
0.010 |
Biomarker
|
disease |
BEFREE |
Haplotype analysis supported our findings of single SNP association, demonstrating that the most significant haplotype, GATAGTTCTC, spanning CFH, CFHR4, and CFHR2 was associated with the greatest risk of developing neovascular AMD (P < 10-6).
|
18541031 |
2008 |
Malignant neoplasm of testis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The familial risks in offspring were high, > 5 for thyroid (FHR 10.7 in all offspring, CI 95% 6.9-16.6), and testicular cancer (FHR 5.4, CI 95% 2.6-11.3), or intermediate, FHR 2-5, for colon, rectal, lung, breast, cervical, uterine, ovarian, skin (melanoma and squamous cell) and other endocrine gland cancers.
|
9754648 |
1998 |
Malignant Testicular Germ Cell Tumor
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The familial risks in offspring were high, > 5 for thyroid (FHR 10.7 in all offspring, CI 95% 6.9-16.6), and testicular cancer (FHR 5.4, CI 95% 2.6-11.3), or intermediate, FHR 2-5, for colon, rectal, lung, breast, cervical, uterine, ovarian, skin (melanoma and squamous cell) and other endocrine gland cancers.
|
9754648 |
1998 |